Patent details

92381 Product Name: Macitentan et ses dérivés pharmaceutiquement acceptables

Basic Information

Publication number:
92381
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP019895705
Legal Status:
Active
Application number:
92381
First applicant's nationality:
Procedural language:
French

Paediatric Extension

SPC Extension Filing Date:
22/11/2024
SPC Extension Agent Name:
OFFICE FREYLINGER S.A.
SPC Extension Status:
Granted
SPC Extension Grant Date:
24/11/2025
SPC Extension Rejection Date:

Marketing Authorization

Marketing Authorization Number:
EU/1/13/893 - OPSUMIT - macitentan
Marketing Authorization Type:
Marketing Authorization Date:
20/12/2013
Marketing Authorization Status:
Accepted
Marketing Authorization Country:

Dates

Filing date:
26/02/2014
First Marketing Authorization date:
20/12/2013
Grant date:
28/04/2014
Activation date:
04/12/2021
Publication date:
28/04/2014
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
04/12/2026
SPC Extension Expiration:
04/06/2027
Rejection date:
Withdrawal date:

Owner

From:
26/02/2014
 
 

Name:
Actelion Pharmaceuticals Ltd.
Address:
Gewerbestrasse 16, 4123 Allschwil, Switzerland (CH)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
26/02/2014
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
BOSS Christoph
Address:
Switzerland (CH)

2

Name:
FISCHLI Walter
Address:
Switzerland (CH)

3

Name:
CLOZEL Martine
Address:
France (FR)

4

Name:
BOLLI Martin
Address:
Switzerland (CH)

5

Name:
WELLER Thomas
Address:
Switzerland (CH)

Publication

Bulletin

1

Bulletin Heading:
SPCX1
Bulletin edition number:
2024/14
Publication date:
06/12/2024
Description:
Section G : Applications for extensions for pediatric use – I1E publication

2

Bulletin Heading:
SPC3
Bulletin edition number:
2025/04
Publication date:
04/03/2025
Description:
Section E : Supplementary Protection certificates entered into force – IA publication

3

Bulletin Heading:
SPCX2
Bulletin edition number:
2025/13
Publication date:
04/12/2025
Description:
Section H : Granted extensions for pediatric use of supplementary protection certificates – I2E publication

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
28/11/2025
Last Annual Fee Paid Number:
25
Last Annual Fee Paid Amount:
450 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
22/11/2024 Application Form 3
22/11/2024 Paediatric investigation plan 1
22/11/2024 Outgoing Correspondence 1
22/11/2024 General Document 2
22/11/2024 Marketing authorization 3
22/11/2024 Summary of the product caracteristics 64
22/11/2024 Publication 1
24/11/2025 Publication 1
24/11/2025 Certificate 1
22/11/2024 FNET_DC_FRONTPAGE 1
24/11/2025 Outgoing Correspondence 1